The role of anti-inflammatory drugs in colorectal cancer

D Wang, RN DuBois - Annual review of medicine, 2013 - annualreviews.org
A large body of evidence indicates that genetic mutations, epigenetic changes, chronic
inflammation, diet, and lifestyle are key risk factors for colorectal cancer (CRC). Prevention of …
被引用次数：148 相关文章

The role of anti-inflammatory drugs in colorectal cancer.

D Wang, RN DuBois - Annual Review of Medicine, 2012 - europepmc.org
A large body of evidence indicates that genetic mutations, epigenetic changes, chronic
inflammation, diet, and lifestyle are key risk factors for colorectal cancer (CRC). Prevention of …

The Role of Anti-Inflammatory Drugs in Colorectal Cancer

D Wang, RN DuBois - Annual Review of Medicine, 2013 - cir.nii.ac.jp
抄録< jats: p> A large body of evidence indicates that genetic mutations, epigenetic
changes, chronic inflammation, diet, and lifestyle are key risk factors for colorectal cancer …

The role of anti-inflammatory drugs in colorectal cancer

D Wang, RN DuBois - Annual review of medicine, 2013 - pubmed.ncbi.nlm.nih.gov
A large body of evidence indicates that genetic mutations, epigenetic changes, chronic
inflammation, diet, and lifestyle are key risk factors for colorectal cancer (CRC). Prevention of …

The role of anti-inflammatory drugs in colorectal cancer

D Wang, RN DuBois - Annual Review of Medicine, 2013 - asu.elsevierpure.com
A large body of evidence indicates that genetic mutations, epigenetic changes, chronic
inflammation, diet, and lifestyle are key risk factors for colorectal cancer (CRC). Prevention of …